TrialThe Journal of clinical investigation2022

Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer.

Jason M Redman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.